普通外文研报
Colgate-Palmolive (India) Limited Balanced growth with stable margins ahead; Raising estimates
研报英文原文证据摘录
Colgate-Palmolive (India) Limited Balanced growth with stable margins ahead; Raising estimates
J P M O R G A N Asia Pacific Equity Research
25 May 2026
Colgate-Palmolive (India) Limited Neutral
COLG.NS, CLGT IN
Balanced growth with stable margins ahead; Raising Price (22 May 26):Rs2,156.90
estimates ▲Price Target (Jun-27):Rs2,250.00 Prior (Mar-27):Rs2,000.00
CLGT’s Q4 operational performance was ahead of our and street expectations.
Domestic sales accelerated to 9.2% (off a benign base), driven equally by pricing and Consumer, Retail, Media
volume. On the annual investor call, management shared its focus on driving balanced Latika Chopra, CFA AC
growth (vol and price) in the coming quarters along with sustained higher brand (91-22) 6157-3584
investments (better elasticity to demand particularly for the premium portfolio seen) latika.chopra@jpmorgan.com
implying range bound EBITDA margin outlook (despite scope for further Himanshu Singh
improvement for already strong gross margins). Category development, (91-22) 6157-3610
himanshu.x6.singh@jpmorgan.com
Premiumization and scaling up toothbrushes/personal care are at the centre of
Saransh S Gokhale
CLGT’s growth strategy, supported by superior mix (technology and science backed
(91-22) 6157 3578
innovation, packaging), effective communication and improved on ground execution saransh.gokhale@jpmchase.com
(increased direct reach, rural initiatives, faster growth in growth/margin/market share J.P. Morgan India Private Limited, J.P. Morgan
accretive E-commerce channel). Amidst rising cost inflation scenario, CLGT expects Tower,Registration:Santacruz(E),INH000001873,Mumbai (91-22)- 400098,6157-3000.SEBI
to mitigate the margin impact via prudent price hikes, productivity/cost efficiencies,
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器